Compatibility «EsCordi Cor» and «Dexona»

• Interactions EsCordi Cor with Dexona

  • Dangerous interactions
    • ⓘ Calcium channel blockers(C08) + Drugs that cause hypokalemia; Glucocorticosteroids (C03A, A01AB04,J02AA01,H02,D07 => Increases the likelihood of ventricular tachycardia and ventricular fibrillation. (A dangerous combination, it is necessary to eliminate hypokalemia before use).
  • Negative interactions
    • ⓘ Concomitant use with potent or moderate inhibitors of the CYP3A4 isoenzyme may lead to a significant increase in systemic exposure to amlodipine.
    • ⓘ Blood pressure should be carefully monitored while using amlodipine with inducers of the CYP3A4 isoenzyme.
    • ⓘ The antihypertensive effect of the drug is weakened by alpha-adrenomimetics, sympathomimetics, estrogens, glucocorticosteroids (sodium and fluid retention).
    • ⓘ This result was not observed in individuals who did not express CYP3A5 (n=6).
    • ⓘ However, a 3-fold increase in plasma exposure to tacrolimus was reported in a kidney transplant patient (non-CYP3A5 expressor) after starting amlodipine for the treatment of post-transplant hypertension, which led to a decrease in the dose of tacrolimus.
    • ⓘ Regardless of the status of the CYP3A5 genotype, the possibility of interaction with these drugs cannot be excluded.
    • ⓘ Reduction of the antihypertensive effect of amlodipine (due to fluid retention and sodium ions as a result of the action of corticosteroids).
    • ⓘ Inhibitors of the CYP3A4 isoenzyme.
    • ⓘ Since amlodipine is a weak inhibitor of CYP3A4, the exposure of mTOR inhibitors may increase when used together.
    • ⓘ Caution should be exercised when using dexamethasone (CYP3A4 inducer) with amlodipine at the same time due to a possible increase in hepatic metabolism of amlodipine (CYP3A4 substrate).
    • ⓘ Caution should be exercised and the therapeutic response monitored when using CYP3A4 inducers, such as dexamethasone, with amlodipine (CYP3A4 substrate), etc.; an increase in hepatic metabolism of amlodipine is possible.
  • No interactions
    • ⓘ There is no data on the effect of inducers of the CYP3A4 isoenzyme on the pharmacokinetics of amlodipine.
  • Positive interactions
    • ⓘ A prospective study involving healthy volunteers from China (n=9), CYP3A5 expressers, showed an increase in tacrolimus exposure by 2.5-4 times when used concomitantly with amlodipine compared with the use of tacrolimus alone.
    • ⓘ An increase in the dose of amlodipine may be required.
  • Unclear interactions
    • ⓘ CYP3A4 inhibitors.
    • ⓘ CYP3A4 inducers.
    • ⓘ Corticosteroids (mineral.
    • ⓘ And glucocorticosteroids), tetracosactide.
    • ⓘ Amiodarone, amlodipine + amiodarone.

Decoding the colors of interactions and contraindications

Dangerous	—	a pronounced negative interaction or contraindication.
Negative	—	negative interaction or side effect that may reduce effectiveness.
Positive	—	the interaction can SOMETIMES be used as a positive (often a dose adjustment is needed), or it is an indication of the drug.
No	—	the drugs do NOT interact, which is separately indicated in the instructions.
Unclear	—	the system failed to pre-assess the danger.

Video instruction

▶

Look at ▶Youtube

Additional information

• Kiberis checks interactions and evaluates drug compatibility for free online right in the instructions thanks to the latest artificial intelligence technologies. The accuracy of finding is more than 95%, the accuracy of the hazard assessment is more than 80%. The online medical service takes into account all the drug groups of the selected drugs and all their components. And since the database contains 25,000 drugs with detailed instructions, not every pharmacologist can compete with our artificial intelligence. List of popular interactions.
• Why do I need to
  • Avoid dangerous prescriptions for your patients.
  • Check the contraindications.
  • Evaluate the safety of therapy in the treatment of children.
  • See the compatibility of drugs with alcohol (enter it as a drug).
  • Point the doctor to the found interaction - you may need to adjust the therapy.
  • Do you need an API for interactions/drug analogues for your project? Write to us.
• The use of information about interactions is only possible as an introduction. This information should not be used to adjust therapy without consulting a specialist.
• The article is written: artificial intelligence Kiberis
• Sources: official instructions for medicines and their active substances, as well as inter-group interactions described in medical studies and textbooks.
• Total analyzed: 169,990,749 possible combinations of drugs and their components were found 412,526 interacting combinations.
• Medicine section: Standard evidence-based medicine
• The date of the last update of the interaction database: 2024-11-07

Category - medicine